Jones Financial Companies
CELU icon

Jones Financial Companies’s Celularity CELU Stock Holding History

Jones Financial Companies’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$100 Hold
82
– – ﹤0.01% 4639
2025
Q4 		$91 Hold
82
– – ﹤0.01% 4322
2025
Q3 		$185 Hold
82
– – ﹤0.01% 4136
2025
Q2 		$152 Buy
+82
New +$149 ﹤0.01% 3929

Other funds holding CELU

CVSC
C.V. Starr & Co New York $192M AUM 35.69% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $716M AUM 21.09% 1-Year Est. Return

Jones Financial Companies's CELU Position: Q1 2026 in Review

Jones Financial Companies held its Celularity (CELU) position steady in Q1 2026 at 82 shares worth $100. The position accounts for ﹤0.01% of the portfolio, ranked #4639.

Jones Financial Companies first reported a position in CELU in Q2 2025 and has held it in 4 quarters since. The position peaked at $185 in Q3 2025. 38 funds tracked by Wall St. Rank hold CELU as of Q1 2026.

  • Jones Financial Companies held 82 shares of Celularity worth $100 as of Q1 2026.
  • Jones Financial Companies left its Celularity share count unchanged in Q1 2026.
  • Celularity made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #4639 holding.
  • Jones Financial Companies first reported a position in Celularity in Q2 2025 and has held it in 4 quarters since.
  • Jones Financial Companies's Celularity position peaked at $185 in Q3 2025.
  • 38 funds tracked by Wall St. Rank held Celularity as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.